| First Author | Mancuso M | Year | 2011 |
| Journal | Cancer Lett | Volume | 308 |
| Issue | 2 | Pages | 197-202 |
| PubMed ID | 21636213 | Mgi Jnum | J:173607 |
| Mgi Id | MGI:5049795 | Doi | 10.1016/j.canlet.2011.05.004 |
| Citation | Mancuso M, et al. (2011) The estrogen receptor beta agonist diarylpropionitrile (DPN) inhibits medulloblastoma development via anti-proliferative and pro-apototic pathways. Cancer Lett 308(2):197-202 |
| abstractText | Gender-related differences in medulloblastoma (MB) development have been reported with a higher incidence in males (slightly above 60%) than in females, female gender being also a significantly favorable prognostic factor in MB. The present study focused on the evaluation of the mechanisms by which estrogens protect against MB formation. To this end, we used a well characterized mouse model of MB |
